| Bill | HR 8289 |
|---|---|
| Type of Legislation | House Bill |
| Congress | 117 |
| Status | Archived — 117th Congress concluded |
| Source | View original on Congress.gov |
Geographic Scope
National
Description
Banning Misleading Drug Ads Act of 2022
This bill finalizes a 2010 proposed rule from the Food and Drug Administration (FDA) regarding television and radio prescription drug advertisements if the FDA does not otherwise issue a final rule within 180 days of the bill's enactment. (The proposed rule specifies standards for major statements about a drug's side effects in television and radio advertisements.)
Bill Title
Banning Misleading Drug Ads Act of 2022
Linked Goals
Steps
- 2022-07-05: Referred to the House Committee on Energy and Commerce.
- 2022-07-05: Introduced in House
- 2022-07-05: Introduced in House
Projected Outcome
A more informed proposal or public response aligned with the Promote General Welfare goal.